Your browser doesn't support javascript.
loading
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients.
Haberbosch, Linus; Maurer, Lukas; Sandforth, Arvid; Wernicke, Charlotte; Spranger, Joachim; Mai, Knut; Jumpertz von Schwartzenberg, Reiner.
Afiliación
  • Haberbosch L; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Maurer L; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sandforth A; Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, University of Tübingen, Tübingen, Germany.
  • Wernicke C; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Partner of the German Center for Diabetes Research (DZD), Germany.
  • Spranger J; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Mai K; Department of Endocrinology and Metabolism, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Jumpertz von Schwartzenberg R; Charité Center for Cardiovascular Research, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Endocr Relat Cancer ; 29(3): 121-128, 2022 02 03.
Article en En | MEDLINE | ID: mdl-35014973
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Corteza Suprarrenal / Carcinoma Corticosuprarrenal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Corteza Suprarrenal / Carcinoma Corticosuprarrenal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania